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Propolis is a resinous product collected by honey bees. It was also reported that propolis has a wide variety of biological actions,
including antimicrobial activity and antioxidant, anti-inﬂammatory, and suppressive eﬀects of dioxin toxicity activities. The aim
of this study was to compare the in vitro cytotoxic activities of green propolis (G12) and red propolis (G13) in human leukemia
cells. These cells were incubated with diﬀerent concentrations of propolis and 48 hours after the IC50 was calculated for each cell.
The results showed that the red propolis has cytotoxic eﬀect in vitro higher than green propolis. Red propolis was showed to be
cytostatic in K562 cells and caused the same amount of apoptosis as its control Gleevec. In conclusion, these results showed that
red propolis is more cytotoxic than the green propolis in a variety of human cell lines of leukemia. Red propolis may contain drugs
capableofinhibitingcancercellgrowth.Therefore,furtherisolationofrespectivechemicalingredientsfromtheredpropolis(G13)
for identiﬁcation of the activities is necessary.
1.Introduction
Propolis is a resinous product collected by honey bees (Apis
mellifera) from tree exudates mainly resins of leaf bud mixed
withbeeswaxtoformasealingmaterialintheirhoneycombs,
smooth out the internal walls, and protect the entrance
against intruders [1]; it was also reported that propolis has
a wide variety of biological actions, including antimicrobial
activity [2], antiherpes [3], and suppressive eﬀects of dioxin
toxicity [4]. Because of the wide range of biological activities,
recently propolis has also been extensively used in food and
beverages to improve health and diseases [5].
The medical application of propolis preparation had
led to increased interest in its chemical composition and
its botanical origins, because so far mainly polyphenols
being ﬂavonoids aglycones, and its derivatives. The chemical
composition of the main ﬂavonoids in propolis has been
found to be quantitatively variable, depending on the
environmental plant ecology [6, 7]. Therefore, we have
collected 600 samples of propolis obtained by Africanized
Apis mellifera in Brazil and then analyzed all samples. We
found that Brazilian propolis is classiﬁed into 13groups
based on physicochemical characteristics. Among all groups
of propolis, group 12, which is known as green propolis,
is widely used mainly for ingredients of functional food
and pharmaceutical purposes and the botanical origin of
propolisgroup12wastheresinofBaccharisdracunculifoliain
southeastern Brazil [7]. We evaluated the eﬀect of ethanolic
extracts of the propolis group 12 and bud resins of botanical
origin of propolis group 12 on proliferation of metastasis
and primary tumor-derived human prostate carcinoma and
observed that both samples induced growth inhibition that
was associated with S phase arrest [8].
Recently, we found reddish propolis in beehives located
along the sea and river shores in northeastern Brazil. We2 Evidence-Based Complementary and Alternative Medicine
observed that bees kept in that area were collecting the
red exudates on the surface of Dalbergia ecastaphyllum (L)
Taud., which is the botanical origin of propolis group 13,
and both samples of the red plant exudates and the propolis
were analyzed and it was found that both samples contained
similar ingredients [9] .T h eo b j e c t i v eo ft h i sp a p e rw a st o
investigate the eﬀect of ethanolic extracts of propolis group
12 (G12) and propolis group 13 (G13) in human leukemia
cells.
2.MaterialsandMethods
2.1. Preparation of Ethanolic Extracts of Propolis. Recently,
Brazilian propolis has been classiﬁed into 13 groups. Among
these 13 groups of propolis, groups 12 and 13 were used
for this investigation. Propolis group 12 was collected in
the southeastern region in Brazil such as the state of S˜ ao
Paulo and Minas Gerais, and we have observed that bees
(Africanized Apis mellifera) were visiting mainly bud or
unexpanded leaves of Baccharis dracunculifolia (Composi-
tae). In case of propolis group 13, the propolis was collected
from beehives located in woody perennial shrubs along the
sea and river shores in northeastern Brazil. It was observed
that the bees visited mainly Dalbergia ecastaphyllum (L)
Taud. (Leguminosae) to collect the red resinous exudates on
its surface and from holes in the branches. Consequently, the
color of propolis group 13 is also red. Two ethanolic extracts
of propolis groups 12 and 13 were prepared as follows. Each
group of propolis sample (50g) was extracted with 600mL
of 80% (v/v) ethanol at 60◦C for 30min. After, extraction,
the mixture was centrifuged and the supernatants were
individually evaporated to complete dryness at 40◦Ca n d
the resulting powder was designated as ethanolic extracts of
propolis. These ethanolic extracts of propolis were analyzed
by reversed-phase high-performance liquid chromatography
(RPHPLC) and the results are shown in Figure 1 and Table 1.
2.2. Cell Lines. The cell lines used in this study were, K562,
chronic myelogenous human leukemia [10], HL60, acute
promyelocytic leukemia [11], NB4, human acute promye-
locytic leukemia [12], Ramos human Burkitt lymphoma
[13], Raji human Burkitt lymphoma [14], Nalm16 [15]
and Nalm6, human B cell precursor leukemia [16], RS4,
human B cell precursor leukemia [17], B15, human B cell
precursor leukemia [18], and REH, human B cell precursor
leukemia [19]. The cells were grown in plastic bottles
(25cm3) containing RPMI 1640 (Sigma R6504) medium
supplemented with 10% fetal calf serum (Gibco 16000-044),
1% penicillin (10000IU/mL), and streptomycin (10mg/mL)
(Gibco 15070) at 37◦C in humidiﬁed air with 5% CO2.T h e
medium was changed every 48h.
2.3. Cytotoxicity Assays. The cytotoxicity of each propolis in
the cell lines indicated above was determined by the MTT
(3-(4,5-dimethylthiazol-2-yl)-2-5 diphenyl tetrazolium bro-
mide) assay. MTT is captured by cells and reduced intra-
cellularly in a mitochondrion-dependent reaction to yield




















































groups 12 and 13.
provides an indication of their intactness and mitochondrial
activity that serves as a measure of viability [20]. After a
48h incubation with propolis (seven concentrations on a
logarithmic scale from 1 to 1000µg/mL), the plates were
centrifuged to pellet the cells, the supernatant was removed,
and 10µL of MTT (Sigma, M5665) dissolved in 100µL
of phosphate-buﬀered saline (Sigma P4417) was added
followed by incubation for 4h at 37◦C in a humid, 5% CO2
atmosphere. After this period, the plates were centrifuged
again, the supernatant was removed, and the insoluble
formazan crystals were dissolved in 150µLo fI s o p r o p y l
alcohol. The absorbance was read in a Synergy ELISA plate
reader (Bio Tek Instruments, Highland Park, Winooski,
USA) at 570nm. The results were expressed as percentage
inhibition relative to control cells (considered as 100%).
2.4. Trypan Blue Exclusion Test. Aliquots of K562 and
Nalm16 cells (3 ×106/mL, 1mL/well) were plated in six-well
culture plates (Corning, New York, NY, USA) containing
RPMI 1640 medium supplemented with 10% heat inacti-
vated fetal bovine serum (FBS) (Gibco 1600-044), 1% L-
glutamine, 50U/mL penicillin, and 50mg/mL streptomycin,
followed by the addition of group 12 or group 13 propolis
and a cytotoxic reference drug. The cells were incubated in
a ﬁnal volume of 10mL for 24, 48, and 72h at 37◦Ci nEvidence-Based Complementary and Alternative Medicine 3
Table 1: Flavonoids and other chemical constituents of propolis groups 12 and 13, determined by RPHPLC (mg/g−1).
Propolis G12 Propolis G13
Peak no. compound Quantity in mg/g−1 of propolis Peak no. compound Quantity in mg/g−1 of propolis
1 Coumaric acid 10.7 1 Rutin 1.3
2 Ferulic acid 2.4 2 Liquiritigenin 7.1
3 Λ 245 nma + 3 Daidzein 4.3
4 Cinnamic acid 2.6 4 Pinobanksin 6.0
5 Pinobanksin 1.7 5 Λ 251, 292nma +
6 Kaempferol 1.3 6 Quercetin 1.9
7 Isosakuranetin 4.9 7 Luteolin 2.1
8 Chrysin 1.9 8 Λ 241, 272, 281nma +
9 Acacetin 6.7 9 Dalbergin 0.9
10 Kaempferide 12.6 10 Isoliquiritigenin 12.1
11 Λ 244nma + 11 Formononetin 19.5
12 Λ 230nma +1 2 Λ 235, 263nma +
13 Λ 245nma + 13 Pinocembrin 7.1
14 Λ 228, 246nma + 14 Pinobanksin 3-acetato 2.6
15 Artepillin C 38.6 15 Biochanin A 1.5
16 Λ 223, 276nma +1 6 Λ 238, 260, 269nma +
17 Λ 233, 249, 329nma +
18 Λ 233, 256nma +
aUnidentiﬁed constituents represent only UV spectral absorption maxim. + Present, but not quantiﬁed.
a humidiﬁed 5% CO2 atmosphere. At each interval, lmL of
cell suspension was withdrawn and mixed with a solution of
0.4% trypan blue (Sigma T6146) to counting the cells in a
Newbauer hemacytometer [21].
2.5. Analysis of Apoptosis by Laser Scanning Cytometry. Flow
cytometry was also used to assess the cytotoxicity of the
propolis extracts and cytotoxic reference drugs in each cell
type [22]. The mode of cell death was analyzed using
TACSAnnexinV-FITCkits(R&DSystems,Inc.Minneapolis,
Minn, USA). The cells were resuspended (3 ×106 cells/mL)
in RPMI 1640 with serum and plated in six-well polystyrene
plates containing culture medium and the propolis or
drug to be tested (ﬁnal concentration: 100µg/mL) prior
to incubation at 37◦C for 1, 3, 6, 12, 24, 48, and 72h.
At the end of each period, the cells were washed once
with 1mL of PBS, centrifuged, and incubated for 15min
in medium containing calcium and annexin-V. The cells
were then washed again and resuspended in 0.4mL of buﬀer
containing propidium iodide (5µg/mL). The samples were
analyzed in a Becton Dickson FACSCanto ﬂow cytometer
in conjunction with FACSDiva software (Becton Dickson
immunocytometry Systems, San Jose, Calif, USA). Control
cells stained with annexin V-FITC or propidium iodide were
used to adjust the cytometer compensation and gating.
2.6. Statistical Analysis. Each propolis extract was screened
six times against all of the cell lines and the results were
expressed as mean ± standard deviation (SD). Cytotoxicity
was assessed by plotting cell survival versus propolis/drug
concentration (on a log scale) followed by sigmoidal curve
ﬁtting and determination of the IC50 by the least squares
method. Boxplots were used to analyze the distribution of
IC50 data and compare the responses to the two propolis
extracts. Diﬀerences between the IC50 for the two propolis
extracts within a given cell line were determined by using
Student’st-testwhereasdiﬀerencesamongtheIC50 valuesfor
a given extract among cell line were assessed by analysis of
variance (ANOVA) followed by Games-Howell pos hoc test,
because there was not homogeneity of variances (P<0.001
f o rL e v e n e ’ st e s t ) .Av a l u eo fP<0.05 indicated signiﬁcance.
All statistical comparisons were done using SPSS software
version 7.5.
3. Results and Discussion
3.1. Cytotoxicity. Figure 2 (Boxplots) showed that the IC50
values for the two propolis extracts in the diﬀerent leukemia
cell lines were signiﬁcantly diﬀerent, with red propolis
(group 13) being more potent cytotoxic in all cases. The
greatest diﬀerences were observed with K562 and HL60
cells and the smallest diﬀerence with RS4 cells. Analysis
of the boxplots in Figure 2 indicated that the responses to
red propolis (G13) were less dispersed within each cell line
and among cell lines (similar IC50 values) than those to
green propolis (group 12), indicating less variation in the
sensitivity of cells to the former extract. The IC50 values for
a given extract among cell line were assessed by analysis of
variance (ANOVA) followed by Games-Howell pos hoc test,
because there was not homogeneity of variances (P< 0.001
in Levene’s test for G12 and G13). ANOVA was positive for
diﬀerences of IC50 a m o n gc e l ll i n e si nb o t he x t r a c t s( P<
0.001 for G12 and P = 0.040 for G13). These indicated that











































































Figure 2: Boxplots of IC50 values for green propolis (G12) and red






































































Figure 3: Results of MTT assay for propolis (G12) and (G13) using
K562 and Nalm6.
within each cell line and among cell lines (similar IC50
values) than those to green propolis (group 12), indicating
less variation in the sensitivity of cells to the former extract.
TheIC50 valuesforthetwopropolisgroupsweresigniﬁcantly
diﬀerent in all cases.
After analyzing the data obtained from MTT, when
comparing the eﬀect of propolis G13 with Gleevec and
cytarabine, there was marked diﬀerence between K562 and
Nalm16 cells. We selected the two cells for testing by trypan
blue exclusion and apoptosis with Annexin V. Figure 3
demonstrated that K562 and Nalm16 the biggest diﬀerence
between the IC50 of G13 and cytarabine (drug used in
clinical oncology) for these two cell extract of propolis
G13 when the compare Gleevec or cytarabine had great
signiﬁcance (P< 0.0001).
3.2. Trypan Blue Exclusion. Using trypan blue solution 0.4%
(Sigma T8154), we quantiﬁed the viability of K562 cells and




































































Figure 4: The kinetics of dye exclusion with Trypan blue.
G13 propolis and compared them to controls and cytarabine
Gleevec. We concluded that a strong cytotoxicity reduced
the number of viable K562 cells after 24 hours treating with
GleevecasshowninFigure 4(a).Whenweobservedtheeﬀect
caused by propolis G13 after 24 hours, there was a citostase
because the number of viable cells is the same as the control.
Observing Figure 4(b),w es e eagra d u a lr e d u ct i o no fc e ll sf o r
cytarabine Nalm16 and a great reduction in viable cells after
48 hours for G13 propolis.
3.3. Apoptosis. By Figure 5(a) it was noted that Gleevec
reached the maximum apoptosis at 12 hours before the G13
propolis; this diﬀerence demonstrated the eﬀectiveness of
drug Gleevec which is the drug chosen for treatment of
chronic myeloid leukemia (here represented by K562) givenEvidence-Based Complementary and Alternative Medicine 5
















































Figure 5: Analysis of apoptosis by laser scanning cytometry.
its eﬃciency; however, it was observed that the G13 could,
after a period of 12 hours, reach a signiﬁcant percentage
of apoptosis which did not occur when comparing the
cytotoxic cytarabine with propolis in Nam16 G13 cell line
(Figure 5(b)). These results were obtained from a single
experiment.
4. Conclusion
These results indicated that propolis G13 is more cytotoxic
than the green propolis (G12) in a variety of human cell
lines of leukemia. G13 propolis contains chemical ingredient
for inhibiting cell growth of certain types of cancer. Nalm16
and K562 cell lines, represent leukemia with high mortality,
and in these trials it was suggested that there is a useful
chemical ingredient in these extracts. K562 chronic myeloid
leukemia is the CML in blast crisis, and the cells carry the
Philadelphia chromosome with a BCR-ABL b3-a2 fusion
gene (Hehlman 2007). In the past, the treatment was done
with antimetabolites (cytarabine, hydroxyurea), alkylating
agents, interferon alpha 2b, and steroids, but these drugs
have been replaced by Gleevec. NALM-16 cell line originated
from peripheral blood of a patient with relapse of leukemia
pro-B lymphocyte in a subacute LLC and bad prognosis and
protocolarmente; in addition to other drugs, cytarabine is
used for treating this leukemia. We provide data to search for
drugs with cytostatic capacity possibly present in the extract
of propolis G13 raising the specter of drugs with potential
therapeutic use in oncology.
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